Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities-Reference-Cited by-同舟云学术

Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Published:2021-04-28 Issue:16 Volume:127 Page:2934-2942
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Stacchiotti Silvia¹^ORCID,Frezza Anna Maria¹^ORCID,Blay Jean‐Yves²^ORCID,Baldini Elizabeth H.³,Bonvalot Sylvie⁴^ORCID,Bovée Judith V. M. G.⁵,Callegaro Dario⁶^ORCID,Casali Paolo G.¹,Chiang RuRu Chun‐ju⁷⁸,Demetri George D.⁹,Demicco Elisabeth G.¹⁰,Desai Jayesh¹¹,Eriksson Mikael¹²,Gelderblom Hans¹³,George Suzanne⁹,Gounder Mrinal M.¹⁴¹⁵,Gronchi Alessandro⁶,Gupta Abha¹⁶¹⁷^ORCID,Haas Rick L.¹⁸¹⁹^ORCID,Hayes‐Jardon Andrea²⁰,Hohenberger Peter²¹,Jones Kevin B.²²,Jones Robin L.²³,Kasper Bernd²¹^ORCID,Kawai Akira²⁴^ORCID,Kirsch David G.²⁵^ORCID,Kleinerman Eugene S.²⁶,Le Cesne Axel²⁷,Lim Jiwon²⁸,Chirlaque López María Dolores²⁹,Maestro Roberta³⁰,Marcos‐Gragera Rafael³¹,Martin Broto Javier³²,Matsuda Tomohiro³³,Mir Olivier²⁷,Patel Shreyaskumar R.³⁴^ORCID,Raut Chandrajit P.³⁵³⁶,Razak Albiruni R. A.¹⁷,Reed Damon R.³⁷^ORCID,Rutkowski Piotr³⁸,Sanfilippo Roberta G.¹,Sbaraglia Marta³⁹,Schaefer Inga‐Marie⁴⁰^ORCID,Strauss Dirk C.²³,Sundby Hall Kirsten⁴¹,Tap William D.¹⁴¹⁵,Thomas David M.⁴²,Graaf Winette T. A.⁴³,Houdt Winan J.⁴⁴,Visser Otto⁴⁵,Mehren Margaret⁴⁶,Wagner Andrew J.⁹^ORCID,Wilky Breelyn A.⁴⁷,Won Young‐Joo²⁸^ORCID,Fletcher Christopher D. M.⁴⁰,Dei Tos Angelo P.³⁹,Trama Annalisa⁴⁸

Affiliation:

1. Department of Medical Oncology National Cancer Institute of Milan Milan Italy

2. Leon Berard Center Claude Bernard University Lyon 1, UNICANCER Hospital Network Lyon France

3. Department of Radiation Oncology Dana‐Farber/Brigham and Women's Cancer Center Boston Massachusetts

4. Department of Surgical Oncology Curie Institute, University of Paris–Sciences and Letters Paris France

5. Department of Pathology Leiden University Medical Center Leiden Netherlands

6. Department of Surgery National Cancer Institute of Milan Milan Italy

7. Taiwan Cancer Registry Center Taipei Taiwan

8. Institute of Epidemiology and Preventive Medicine College of Public Health National Taiwan University Taipei Taiwan

9. Department of Medical Oncology Ludwig Center at Harvard Medical SchoolDana‐Farber Cancer Institute Boston Massachusetts

10. Department of Pathobiology and Laboratory Medicine University of Toronto/Mount Sinai Hospital Toronto Ontario Canada

11. Department of Medical Oncology Peter MacCallum Cancer Center Melbourne Victoria Australia

12. Department of Oncology Skane University Hospital and Lund University Lund Sweden

13. Department of Medical Oncology Leiden University Medical Center Leiden Netherlands

14. Department of Medicine Memorial Sloan Kettering Cancer Center New York New York

15. Weill Cornell Medical College New York New York

16. Division of Hematology/Oncology The Hospital for Sick Children Toronto Ontario Canada

17. Princess Margaret Cancer Center Toronto Ontario Canada

18. Department of Radiotherapy Netherlands Cancer Institute Amsterdam Netherlands

19. Department of Radiotherapy Leiden University Medical Center Amsterdam Netherlands

20. Department of Surgery the Royal Marsden National Health Service Foundation Trust London United Kingdom

21. Sarcoma Unit, Mannheim University Medical Center University of Heidelberg Mannheim Germany

22. Department of Orthopedics University of Utah Salt Lake City Utah

23. Sarcoma Unit Royal Marsden NHS Foundation Trust/Institute of Cancer Research London UK

24. Department of Musculoskeletal Oncology National Cancer Center Hospital Tokyo Japan

25. Department of Radiation Oncology Duke University Medical Center Durham North Carolina

26. Division of Pediatrics The University of Texas MD Anderson Cancer Center Houston Texas

27. Medical Oncology Gustave Roussy Institute Villejuif, Ile‐de‐France France

28. Division of Cancer Registration and Surveillance National Cancer Center, Ilsandong‐gu Goyang‐si Republic of Korea

29. Department of Epidemiology, Regional Health Council, Biomedical Research Institute of Murcia‐Arrixaca Murcia University Murcia Spain

30. Unit of Oncogenetics and Functional Oncogenomics Aviano IRCCS Oncology Referral Center Aviano Italy

31. Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan Department of Health Autonomous Government of Catalonia Catalan Institute of Oncology Girona Spain

32. Medical Oncology Department University Hospital Virgen del Rocio Sevilla Spain

33. National Cancer Registry Section, Center for Cancer Registries, Center for Cancer Control and Information Services, National Cancer Center Tokyo Japan

34. Department of Sarcoma Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas

35. Department of Surgery Brigham and Women's Hospital Boston Massachusetts

36. Center for Sarcoma and Bone Oncology Dana‐Farber Cancer Institute Harvard Medical School Boston Massachusetts

37. Department of Interdisciplinary Cancer Management Moffitt Cancer Center Tampa Florida

38. Department of Soft Tissue/Bone Sarcoma and Melanoma Maria Sklodowska‐Curie National Research Institute of Oncology Warsaw Poland

39. Department of Pathology University Hospital of Padova Padova Italy

40. Department of Pathology Brigham and Women's HospitalHarvard Medical School Boston Massachusetts

41. Department of Oncology the Norwegian Radium HospitalOslo University Hospital Oslo Norway

42. Garvan Institute of Medical Research Sydney New South Wales Australia

43. Department of Medical Oncology Netherlands Cancer Institute Amsterdam Amsterdam Netherlands

44. Department of Surgical Oncology Netherlands Cancer Institute Amsterdam Netherlands

45. Department of Registration Netherlands Comprehensive Cancer Organization Utrecht Netherlands

46. Department of Hematology and Medical Oncology Fox Chase Cancer Center Philadelphia Pennsylvania

47. Department of Medicine University of Colorado Cancer Center Aurora Colorado

48. Evaluative Epidemiology Unit Department of Research National Cancer Institute of Milan Milan Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33618

Reference24 articles.

1. Rare cancers are not so rare: The rare cancer burden in Europe

2. Incidence of rare cancers in the city of São Paulo, Brazil

3. The burden of rare cancers in the United States

4. Incidence and survival of rare cancers in the US and Europe

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical imaging for the diagnosis, recurrence and metastasis evaluation of clear cell sarcoma;World Journal of Clinical Cases;2024-10-16

2. Evaluating the Alignment of Artificial Intelligence‐Generated Recommendations With Clinical Guidelines Focused on Soft Tissue Tumors;Journal of Surgical Oncology;2024-09-05

3. Improving head and neck sarcoma care: The impact of a specialized multidisciplinary team approach on diagnosis and patient outcomes;European Journal of Surgical Oncology;2024-09

4. Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group;ESMO Open;2024-09

5. Clear cell sarcoma in Japan: an analysis of the population-based cancer registry in Japan;Japanese Journal of Clinical Oncology;2024-08-28